9
Disclosures
Jan 30, 2026 — Apr 15, 2026
Date Range
PRIME
Market Segment
Pharmaceutical
Sector

Disclosures

DateTypeHeadlinePDF
Apr 15 Other Daiichi Sankyo Company Daiichi Sankyo to Transfer DSHC Shares to Suntory Holdings in Staged Process PDF
Mar 25 Buyback DAIICHI SANKYO COMPANY: Buys Back 13,854,700 Shares for 40.0 billion PDF
Mar 2 Buyback Daiichi Sankyo Company,Limited Buys Back 14.20 million Shares for 41.8 billion PDF
Feb 26 Admin DAIICHI SANKYO COMPANY,LIMITED Announces Change of Representative Director PDF
Feb 2 Buyback DAIICHI SANKYO REVISES SELF-STOCK ACQUISITION STATUS PDF
Feb 2 Buyback Daiichi Sankyo Company,Limited Buys Back 3.40 million Shares for 10.0 billion PDF
Jan 30 M&A DAIICHI SANKYO COMPANY,LIMITED Announces Simplified Merger of Subsidiary PDF
Jan 30 Earnings DAIICHI SANKYO COMPANY,LIMITED Earnings Presentation: Revenue of 3 million, +0.0% YoY PDF
Jan 30 Earnings DAIICHI SANKYO COMPANY,LIMITED Reports Q3 FY2026 Earnings Presentation: Revenue of 1.37 trillion PDF

Disclosure Types

Buyback: 4 Earnings: 2 Other: 1 Admin: 1 M&A: 1